BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Prostate cancer AND MYH9, P35579, 4627, ENSG00000100345, DFNA17
7 results:

  • 1. Exosomal lincROR Promotes Docetaxel Resistance in prostate cancer through a β-catenin/HIF1α Positive Feedback Loop.
    Jiang X; Xu Y; Liu R; Guo S
    Mol Cancer Res; 2023 May; 21(5):472-482. PubMed ID: 36763128
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Identification of TLN1 as a prognostic biomarker to effect cell proliferation and differentiation in acute myeloid leukemia.
    Cui D; Cui X; Xu X; Zhang W; Yu Y; Gao Y; Mei C; Zheng W
    BMC Cancer; 2022 Sep; 22(1):1027. PubMed ID: 36175877
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. TUBB4A interacts with myh9 to protect the nucleus during cell migration and promotes prostate cancer via GSK3β/β-catenin signalling.
    Gao S; Wang S; Zhao Z; Zhang C; Liu Z; Ye P; Xu Z; Yi B; Jiao K; Naik GA; Wei S; Rais-Bahrami S; Bae S; Yang WH; Sonpavde G; Liu R; Wang L
    Nat Commun; 2022 May; 13(1):2792. PubMed ID: 35589707
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Dose- and time-dependent gene expression alterations in prostate and colon cancer cells after in vitro exposure to carbon ion and X-irradiation.
    Suetens A; Moreels M; Quintens R; Soors E; Buset J; Chiriotti S; Tabury K; Gregoire V; Baatout S
    J Radiat Res; 2015 Jan; 56(1):11-21. PubMed ID: 25190155
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Restoration of compact Golgi morphology in advanced prostate cancer enhances susceptibility to galectin-1-induced apoptosis by modifying mucin O-glycan synthesis.
    Petrosyan A; Holzapfel MS; Muirhead DE; Cheng PW
    Mol Cancer Res; 2014 Dec; 12(12):1704-16. PubMed ID: 25086069
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Somatic mutation analysis of MYH11 in breast and prostate cancer.
    Alhopuro P; Karhu A; Winqvist R; Waltering K; Visakorpi T; Aaltonen LA
    BMC Cancer; 2008 Sep; 8():263. PubMed ID: 18796164
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Serum prostate-specific antigen as a predictor of prostate volume in men with benign prostatic hyperplasia.
    Roehrborn CG; Boyle P; Gould AL; Waldstreicher J
    Urology; 1999 Mar; 53(3):581-9. PubMed ID: 10096388
    [TBL] [Abstract] [Full Text] [Related]  


    of 1.